16 results
10-K
2020 FY
PASG
Passage Bio Inc
3 Mar 21
Annual report
8:01am
pricing program; and
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical
424B1
PASG
Passage Bio Inc
22 Jan 21
Prospectus with pricing info
4:31pm
pharmaceutical pricing program; and
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
DRS
6mkgc4
18 Dec 20
Draft registration statement
12:00am
10-Q
EX-10.1
ej53bvf2uj
11 May 20
Quarterly report
4:06pm
424B4
i4expip5qhw7eiiz6
28 Feb 20
Prospectus supplement with pricing info
4:07pm
S-1
fvsoe7tzy2m5y5qgq7
3 Feb 20
IPO registration
6:39am
S-1
EX-10.6
b0rfq5emw
3 Feb 20
IPO registration
6:39am
DRS/A
sf3cqofdj05wzzi2r
10 Jan 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
uqkhg0fcjzz1fx
10 Jan 20
Draft registration statement (amended)
12:00am
DRS
guebfi5hg3jvy67 rk
6 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next